Hyzaar 100-25 tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FJLEY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,679
Award facts
- Contract value 100% obligated
- $14,679.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $14,679.00 by the Defense Logistics Agency on September 11, 2025, for the supply of Hyzaar 100-25 Tablet in quantities of 90 units. The contract carries an ultimate completion date of September 12, 2025, and does not utilize a set-aside designation. This delivery order represents a continuation of DMS Pharmaceutical Group's substantial role in supporting the federal pharmaceutical supply chain, leveraging its existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier of pharmaceutical products to Department of Defense healthcare facilities nationwide, with a demonstrated portfolio spanning prescription medications, biologics, and medical consumables across multiple therapeutic categories. The company's federal contracting history reflects consistent success in competing for pharmaceutical delivery orders without set-aside protections, underscoring its competitive positioning within the federal procurement marketplace. The Hyzaar tablets being delivered under this award support the medical supply needs of military health facilities, furthering the Defense Logistics Agency's mission to provide comprehensive pharmaceutical support to the Defense Department.
Quick answers
Who was awarded contract SPE2DB25FJLEY?
SPE2DB25FJLEY was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FJLEY worth?
The government has obligated $14,679 on SPE2DB25FJLEY.
Is contract SPE2DB25FJLEY an order under another contract?
Yes. SPE2DB25FJLEY is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLEY competed?
The extent of competition for SPE2DB25FJLEY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award